Hasegawa, Kosei
Shimada, Muneaki
Takeuchi, Satoshi
Fujiwara, Hiroyuki
Imai, Yuichi
Iwasa, Norihiro
Wada, Satoru
Eguchi, Hidetaka
Oishi, Tetsuro
Sugiyama, Toru
Suzuki, Mitsuaki
Nishiyama, Masahiko
Fujiwara, Keiichi
Article History
Received: 17 May 2019
Revised: 23 December 2019
Accepted: 17 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: This study was a prospective study reviewed and approved by the Institutional Review Board of Saitama Medical University International Medical Center, Tottori University Hospital, Iwate Medical University School of Medicine and Jichi Medical University from March 2009 to March 2012. Written and oral informed consent was obtained from all participants, and this study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Data are available through the Development Organization for Frontier Medical Therapeutics (DOFMET) in Japan.
: The authors declare no competing interests.
: This study was supported by the Development Organization for Frontier Medical Therapeutics (DOFMET) in Japan.